
David Planchard/oncostream.com
Apr 5, 2025, 15:36
David Planchard: Thank you to ACS Journal Cancer for the opportunity to publish the review on BRAF lung cancer updates
David Planchard, Thoracic Oncologist, Professor at University Paris Saclay and Head of Thoracic Cancer Group at Gustave Roussy, shared a post by ACS Journal Cancer on X, adding:
“Thank you ACS Journal Cancer for the opportunity to publish this review with my colleague Claudia Parisi on BRAF lung cancer updates!”
Quoting ACS Journal Cancer‘s post:
“Available Open Access from our Targeted Therapies in NSCLC supplement
BRAF in non–small cell lung cancer: From molecular mechanisms to clinical practice.”
Authors: David Planchard and Claudia Parisi
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 5, 2025, 16:02
Apr 5, 2025, 15:21
Apr 5, 2025, 15:16